EP2747562A4 - ESTROGEN RECEPTOR LIGANDS AND METHODS OF USING SAME - Google Patents

ESTROGEN RECEPTOR LIGANDS AND METHODS OF USING SAME

Info

Publication number
EP2747562A4
EP2747562A4 EP12834287.0A EP12834287A EP2747562A4 EP 2747562 A4 EP2747562 A4 EP 2747562A4 EP 12834287 A EP12834287 A EP 12834287A EP 2747562 A4 EP2747562 A4 EP 2747562A4
Authority
EP
European Patent Office
Prior art keywords
methods
estrogen receptor
receptor ligands
ligands
estrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12834287.0A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2747562A1 (en
Inventor
James Dalton
Mitchell S Steiner
Christopher C Coss
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncternal Therapeutics Inc
Original Assignee
GTx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/215,679 external-priority patent/US9427418B2/en
Application filed by GTx Inc filed Critical GTx Inc
Priority claimed from PCT/US2012/052141 external-priority patent/WO2013043304A1/en
Publication of EP2747562A1 publication Critical patent/EP2747562A1/en
Publication of EP2747562A4 publication Critical patent/EP2747562A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
EP12834287.0A 2011-08-23 2012-08-23 ESTROGEN RECEPTOR LIGANDS AND METHODS OF USING SAME Withdrawn EP2747562A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/215,679 US9427418B2 (en) 2009-02-23 2011-08-23 Estrogen receptor ligands and methods of use thereof
PCT/US2012/052141 WO2013043304A1 (en) 2009-02-23 2012-08-23 Estrogen receptor ligands and methods of use thereof

Publications (2)

Publication Number Publication Date
EP2747562A1 EP2747562A1 (en) 2014-07-02
EP2747562A4 true EP2747562A4 (en) 2015-05-06

Family

ID=48444651

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12834287.0A Withdrawn EP2747562A4 (en) 2011-08-23 2012-08-23 ESTROGEN RECEPTOR LIGANDS AND METHODS OF USING SAME

Country Status (10)

Country Link
EP (1) EP2747562A4 (enrdf_load_stackoverflow)
JP (1) JP2014524479A (enrdf_load_stackoverflow)
KR (1) KR20140064906A (enrdf_load_stackoverflow)
CN (1) CN103957706A (enrdf_load_stackoverflow)
AU (1) AU2012312902B2 (enrdf_load_stackoverflow)
CA (1) CA2845890A1 (enrdf_load_stackoverflow)
IL (1) IL231070A0 (enrdf_load_stackoverflow)
IN (1) IN2014DN01959A (enrdf_load_stackoverflow)
MX (1) MX2014002105A (enrdf_load_stackoverflow)
RU (1) RU2014111060A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018342909B2 (en) * 2017-09-27 2023-06-08 Targimmune Therapeutics Ag Castration resistant prostate cancer
CA3128331C (en) * 2019-01-30 2024-06-18 Margaret K. YU Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer
WO2020157334A1 (en) * 2019-02-01 2020-08-06 Fondazione Per L'istituto Oncologico Di Ricerca (Ior) Methods of treating castrate-resistant prostate cancer

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062230A2 (en) * 2005-11-28 2007-05-31 Gtx, Inc. Nuclear receptor binding agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
US8546451B2 (en) * 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
KR20130101146A (ko) * 2009-02-23 2013-09-12 지티엑스, 인코포레이티드 에스트로겐 수용체 리간드 및 그 이용 방법

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007062230A2 (en) * 2005-11-28 2007-05-31 Gtx, Inc. Nuclear receptor binding agents

Also Published As

Publication number Publication date
IL231070A0 (en) 2014-03-31
AU2012312902A1 (en) 2013-05-23
KR20140064906A (ko) 2014-05-28
IN2014DN01959A (enrdf_load_stackoverflow) 2015-05-15
CN103957706A (zh) 2014-07-30
JP2014524479A (ja) 2014-09-22
MX2014002105A (es) 2014-09-25
EP2747562A1 (en) 2014-07-02
AU2012312902B2 (en) 2016-03-17
RU2014111060A (ru) 2015-09-27
CA2845890A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
IL284407B (en) Opioid receptor ligands and methods for their use and preparation
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
ZA201403760B (en) Anti-cd98 antibodies and methods of use thereof
IL232055B (en) Anti-1htra antibodies and methods of use
EP2791132A4 (en) ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
IL238227A0 (en) Antibodies against c16orf54 and uses thereof
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
IL228072A0 (en) Alkyl-substituted quinazoline compounds and methods of use
IL214805A0 (en) Estrogen receptor ligands and methods of use thereof
EP2538780A4 (en) STROGEN RECEPTOR LIGANDS AND METHODS OF USE
EP2709999A4 (en) QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE
IL230585A (en) Estrogen receptor ligands
EP2747562A4 (en) ESTROGEN RECEPTOR LIGANDS AND METHODS OF USING SAME
HK1173619A (en) Estrogen receptor ligands and methods of use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140305

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RA4 Supplementary search report drawn up and despatched (corrected)

Effective date: 20150408

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/00 20060101ALI20150331BHEP

Ipc: A61K 45/06 20060101ALI20150331BHEP

Ipc: A61K 31/167 20060101AFI20150331BHEP

Ipc: A61K 31/137 20060101ALI20150331BHEP

Ipc: A61K 31/4453 20060101ALI20150331BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180301